Wasatch Advisors LP Purchases New Position in Pediatrix Medical Group, Inc. $MD

Wasatch Advisors LP purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,050,524 shares of the company’s stock, valued at approximately $43,861,000.

Several other large investors have also recently added to or reduced their stakes in the company. Louisiana State Employees Retirement System bought a new stake in Pediatrix Medical Group during the first quarter worth about $798,000. Ritholtz Wealth Management raised its stake in shares of Pediatrix Medical Group by 42.1% in the first quarter. Ritholtz Wealth Management now owns 143,668 shares of the company’s stock valued at $3,073,000 after acquiring an additional 42,553 shares during the last quarter. Evolve Private Wealth LLC boosted its holdings in shares of Pediatrix Medical Group by 12.7% in the 1st quarter. Evolve Private Wealth LLC now owns 33,115 shares of the company’s stock worth $708,000 after acquiring an additional 3,733 shares in the last quarter. Diversified Trust Co boosted its holdings in shares of Pediatrix Medical Group by 12.7% in the 1st quarter. Diversified Trust Co now owns 26,433 shares of the company’s stock worth $565,000 after acquiring an additional 2,982 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its position in Pediatrix Medical Group by 814.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock worth $12,713,000 after acquiring an additional 529,367 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Price Performance

MD opened at $24.60 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. The stock has a market capitalization of $2.02 billion, a P/E ratio of 11.94 and a beta of 0.69. The company’s 50 day simple moving average is $22.89 and its 200-day simple moving average is $21.75. Pediatrix Medical Group, Inc. has a one year low of $11.84 and a one year high of $24.99.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter in the previous year, the company posted $0.33 EPS. Pediatrix Medical Group’s revenue was up 3.9% on a year-over-year basis. Sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a report on Monday, April 20th. Truist Financial boosted their price objective on Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, April 13th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a report on Friday, May 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday. Finally, UBS Group raised their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $22.50.

Insider Activity at Pediatrix Medical Group

In other news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.80% of the company’s stock.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.